Enzyme Research

Executive Summary

Enzyme Research Laboratories (ERL) is a privately held manufacturer of high-purity coagulation proteins, enzymes, cofactors, and antibodies derived from human and animal plasmas. Founded in 1995 and headquartered in South Bend, Indiana, the company supplies essential reagents to the global research and diagnostic communities focusing on hemostasis and thrombosis. ERL's products enable scientists to study blood clotting pathways, supporting basic research and clinical diagnostics. As a niche supplier with over 25 years of operation, the company benefits from steady demand in the life sciences sector, particularly from academic labs, biotech companies, and diagnostic manufacturers. While ERL is not a drug developer, its specialized portfolio positions it as a critical component of the hemostasis research ecosystem. The company's private status limits public financial visibility, but its long-standing presence suggests stable operations. Growth opportunities lie in expanding product lines, entering new geographic markets, and capitalizing on the increasing prevalence of coagulation disorders and the corresponding need for diagnostic tools.

Upcoming Catalysts (preview)

• Q4 2026Launch of New Coagulation Factor Panel70% success
• Q1 2027Strategic Partnership with Diagnostic Firm50% success
• Q3 2026ISO 13485 Certification for Quality Management80% success